Finance

Beta
Lists
OBIO:NASDAQ
Orchestra Biomed Holdings Inc
$3.99
+3.37%
(+0.13) 1D
$3.99
0.00% (0.00)
After hours
Closed: Jun 4, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OBIO...
Open
$3.86
High
$4.04
Low
$3.86
Mkt. cap
238.92M
Avg. vol.
250.82K
Volume
0.00
52-wk high
$5.42
52-wk low
$2.20
EPS
-$1.14
Beta
0.51
Shares outstanding
59.88M
No. of employees
86
Open
$3.86
High
$4.04
Low
$3.86
Mkt. cap
238.92M
Avg. vol.
250.82K
Volume
0.00
52-wk high
$5.42
52-wk low
$2.20
EPS
-$1.14
Beta
0.51
Shares outstanding
59.88M
No. of employees
86
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to OBIO in the past 3 months
Strong Buy
Buy
6
Hold
0
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for OBIO in the last 3 months.
Highest
Current $3.99
$20.00 (+401.25%)
Average
$12.83 (+221.55%)
Lowest
$9.00 (+125.56%)
News stories
From sources across the web
About Orchestra Biomed Holdings Inc
CEO-
Employees86
Founded2018
Headquarters-
SectorMedical device
Websiteorchestrabiomed.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
836.00K
861.00K
30.92M
110.00K
Cost of goods sold
46.00K
49.00K
51.00K
32.00K
Cost of revenue
46.00K
49.00K
51.00K
32.00K
Research and development expenses
13.85M
14.03M
16.82M
15.78M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.26M
7.10M
7.29M
6.37M
Operating expense
20.12M
21.12M
24.11M
22.15M
Total operating expenses
20.16M
21.17M
24.16M
22.19M
Operating income
-19.33M
-20.31M
6.75M
-22.08M
Other non operating income
-
-
254.00K
-35.00K
EBT including unusual items
-19.36M
-20.83M
6.24M
-20.69M
EBT excluding unusual items
-19.36M
-20.83M
6.24M
-22.93M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-19.36M
-20.83M
6.24M
-20.69M
Net profit margin
-2,316.15%
-2,419.05%
20.20%
-18,810.00%
Earnings per share
-0.50
-0.40
0.26
-0.33
Interest and investment income
430.00K
-
752.00K
-
Interest expense
-466.00K
-515.00K
-1.52M
-821.00K
Net interest expenses
-36.00K
-515.00K
-763.00K
-821.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-19.25M
-20.23M
6.84M
-21.99M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer